Revolution Medicines Inc (NASDAQ:RVMD) shares, rose in value on Friday, March 28, with the stock price down by -1.97% to the previous day’s close as strong demand from buyers drove the stock to $37.35.
Actively observing the price movement in the last trading, the stock closed the session at $38.10, falling within a range of $37.03 and $38.09. The value of beta (5-year monthly) was 1.457. Referring to stock’s 52-week performance, its high was $62.40, and the low was $29.55. On the whole, RVMD has fluctuated by -4.43% over the past month.
With the market capitalization of Revolution Medicines Inc currently standing at about $6.94 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-25.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RVMD’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of RVMD currently trading nearly -3.11% and -7.33% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.32, while the 7-day volatility ratio is showing 3.39% which for the 30-day chart, stands at 4.25%. Furthermore, Revolution Medicines Inc (RVMD)’s beta value is 1.34, and its average true range (ATR) is 1.51.
A comparison of Revolution Medicines Inc (RVMD) with its peers suggests the former has fared considerably weaker in the market. RVMD showed an intraday change of -1.97% in last session, and over the past year, it grew by 24.50%%.
Data on historical trading for Revolution Medicines Inc (NASDAQ:RVMD) indicates that the trading volumes over the past 10 days have averaged 1.08 and over the past 3 months, they’ve averaged 1.30 million. According to company’s latest data on outstanding shares, there are 185.90 million shares outstanding.
Nearly 13.04% of Revolution Medicines Inc’s shares belong to company insiders and institutional investors own 94.01% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 16.65 million shares as on 2025-03-14, resulting in a short ratio of 11.88. According to the data, the short interest in Revolution Medicines Inc (RVMD) stood at 948.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 14.92 million. The stock has fallen by -14.61% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RVMD stock heading into the next quarter.
